Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,613 | 527 | 99.5% |
| Education | $38.76 | 7 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,315 | 39 | $0 (2024) |
| Amgen Inc. | $879.06 | 66 | $0 (2023) |
| GlaxoSmithKline, LLC. | $690.15 | 65 | $0 (2024) |
| Novo Nordisk Inc | $600.24 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $529.05 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $470.61 | 33 | $0 (2021) |
| PFIZER INC. | $426.52 | 40 | $0 (2023) |
| Lilly USA, LLC | $396.20 | 39 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $392.02 | 26 | $0 (2023) |
| Allergan, Inc. | $337.91 | 22 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.56 | 8 | Bayer Healthcare Pharmaceuticals Inc. ($32.93) |
| 2023 | $293.42 | 16 | Novartis Pharmaceuticals Corporation ($54.30) |
| 2022 | $128.61 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($39.46) |
| 2021 | $1,273 | 86 | AstraZeneca Pharmaceuticals LP ($196.98) |
| 2020 | $857.21 | 54 | AstraZeneca Pharmaceuticals LP ($172.99) |
| 2019 | $1,595 | 111 | AstraZeneca Pharmaceuticals LP ($341.51) |
| 2018 | $1,689 | 117 | AstraZeneca Pharmaceuticals LP ($327.25) |
| 2017 | $1,672 | 134 | Allergan Inc. ($256.31) |
All Payment Transactions
534 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $28.61 | General |
| 10/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: VACCINE | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Cardio-renal | ||||||
| 04/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: DIABETES | ||||||
| 12/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 11/22/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: General - Therapies_NMD | ||||||
| 10/30/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Bone Health | ||||||
| 10/20/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: General - Therapies_NMD | ||||||
| 10/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Cardio-renal | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/17/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/31/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/27/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/13/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Diabetes | ||||||
| 02/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: DIABETES | ||||||
| 01/30/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Bone Health | ||||||
| 01/23/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 411 | 510 | $111,118 | $27,134 |
| 2022 | 10 | 482 | 601 | $85,464 | $30,305 |
| 2021 | 12 | 547 | 729 | $97,775 | $35,336 |
| 2020 | 13 | 574 | 806 | $107,877 | $34,241 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 142 | $51,546 | $10,307 | 20.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $23,808 | $7,642 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 77 | $19,712 | $3,195 | 16.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $6,175 | $1,983 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $6,643 | $1,633 | 24.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 97 | 130 | $910.00 | $891.80 | 98.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $847.00 | $830.06 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $312.18 | 81.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 16 | $384.00 | $152.32 | 39.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $600.00 | $146.86 | 24.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 18 | $108.00 | $39.60 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 185 | $42,920 | $13,012 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $17,608 | $8,544 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 95 | $15,010 | $4,238 | 28.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 15 | 15 | $5,505 | $2,351 | 42.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $1,560 | $891.02 | 57.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $560.00 | $436.32 | 77.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 117 | 147 | $1,029 | $435.36 | 42.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 21 | 23 | $552.00 | $220.84 | 40.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $576.00 | $126.05 | 21.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 20 | 24 | $144.00 | $50.42 | 35.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 125 | 225 | $52,317 | $16,972 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 70 | 70 | $17,360 | $8,712 | 50.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 96 | $15,168 | $4,023 | 26.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 20 | $6,220 | $2,252 | 36.2% |
About Dr. Jeffery Jacobs, M.D
Dr. Jeffery Jacobs, M.D is a Emergency Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740229384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffery Jacobs, M.D has received a total of $7,652 in payments from pharmaceutical and medical device companies, with $142.56 received in 2024. These payments were reported across 534 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,613).
As a Medicare-enrolled provider, Jacobs has provided services to 2,014 Medicare beneficiaries, totaling 2,646 services with total Medicare billing of $127,016. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine, Family Medicine
- Location Omaha, NE
- Active Since 06/06/2006
- Last Updated 07/20/2011
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1740229384
Products in Payments
- FARXIGA (Drug) $493.01
- SYMBICORT (Drug) $414.79
- XARELTO (Drug) $387.91
- Ozempic (Drug) $307.50
- Aimovig (Biological) $274.78
- LINZESS (Drug) $264.96
- Prolia (Biological) $238.94
- TRADJENTA (Drug) $231.10
- TRELEGY ELLIPTA (Drug) $226.24
- ENTRESTO (Drug) $223.08
- EVENITY (Biological) $209.56
- TRULICITY (Drug) $187.14
- CHANTIX (Drug) $184.28
- FASENRA (Biological) $158.18
- STIOLTO RESPIMAT (Drug) $158.12
- JARDIANCE (Drug) $150.73
- Victoza (Drug) $150.62
- BYDUREON (Drug) $126.97
- TOUJEO (Drug) $126.06
- ANORO (Drug) $119.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Omaha
Srikar Adhikari, Md, MD
Emergency Medicine — Payments: $121,471
Frederick Raiser, Do, DO
Emergency Medicine — Payments: $3,480
Dr. Kevin Ahlers, M.d, M.D
Emergency Medicine — Payments: $2,753
Christopher Jankovich, P.a.-C, P.A.-C
Emergency Medicine — Payments: $1,842
Benjamin Reinhart
Emergency Medicine — Payments: $1,677
Shaila Coffey, Md, MD
Emergency Medicine — Payments: $1,600